PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer

  1. Terán, E.
  2. Lozano, R.
  3. Rodríguez, C.A.
  4. Abad, M.
  5. Figuero, L.
  6. Muñoz, J.A.
  7. Cigarral, B.
  8. Rodrígues, A.
  9. Sancho, M.
  10. Gómez, M.A.
  11. Morchón, D.
  12. Montero, J.C.
  13. Sayagués, J.M.
  14. Ludeña, M.D.
  15. Fonseca, E.
Revue:
Cancer Medicine

ISSN: 2045-7634

Année de publication: 2024

Volumen: 13

Número: 17

Type: Article

DOI: 10.1002/CAM4.70101 GOOGLE SCHOLAR lock_openAccès ouvert editor